Contact
searchSearch
HMP Global

COVID-19 Topic Center

Featured Article

News
COVID-19 Infection Linked to Increased Risk of Skin Conditions
01/08/2025
Grace Taylor, MS, MA
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that...
01/08/2025
First Report Managed Care
News
Financial Hardships Associated With Long COVID Across Income and Education Levels
12/19/2024
Juliet Gallagher
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health...
12/19/2024
First Report Managed Care
News
Effectiveness of SARS-CoV-2 Vaccination Among Health Care Workers
12/17/2024
Hannah Musick
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of...
12/17/2024
First Report Managed Care
News
Patients With MS on Ocrelizumab and Rituximab May Have Higher Risk of SARS-CoV-2 Infection Compared to Ofatumumab
05/28/2024
Hannah Musick
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that...
05/28/2024
First Report Managed Care
Headshots
Commentary
Harnessing Innovation to Improve Maternal Health
04/09/2024

Britteny Matero, partner and senior vice president, Market Access, Innsena, and Jaime Bland, DNP, RN, president and chief executive officer, CyncHealth

Britteny Matero, partner and senior v...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal...
04/09/2024
First Report Managed Care
Headshot of Norman Smith on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Exploring Commercial Coverage, Reimbursement for COVID-19 Vaccines
05/17/2023
Maria Asimopoulos
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer...
05/17/2023
Integrated Healthcare Executive
From Integrated Healthcare Executive
Conference Insider
Down Syndrome Associated With Higher COVID-19 Risk in Pediatric Patients With Hematologic Malignancies
04/13/2023
Maria Asimopoulos
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE,...
04/13/2023
First Report Managed Care
News
Risk of Fatal Overdose Decreased With Expanded Access to Telehealth, Medications for OUD During Pandemic
04/03/2023
Hannah Musick
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less...
04/03/2023
First Report Managed Care
News
SDoH Impact COVID-19 Vaccination Rates Among Patients With Cancer
03/27/2023
Hannah Musick
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and...
03/27/2023
First Report Managed Care
Conference Coverage
Measuring the Pandemic's Impact on Oral Oncolytic Adherence
03/24/2023
Maria Asimopoulos
Researchers at AMCP 2023 studied the number of prescription fills and therapy changes to determine how COVID-19 impacted adherence to oral oncolytic agents.
Researchers at AMCP 2023 studied the number of prescription fills and therapy changes to determine how COVID-19 impacted adherence to oral oncolytic agents.
Researchers at AMCP 2023 studied...
03/24/2023
First Report Managed Care
News
Woman Develops Retroperitoneal Fibrosis Following COVID-19 mRNA Vaccination
03/23/2023
Jolynn Tumolo
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed...
03/23/2023
First Report Managed Care

Newsfeed

News
COVID-19 Infection Linked to Increased Risk of Skin Conditions
01/08/2025
Grace Taylor, MS, MA
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that...
01/08/2025
First Report Managed Care
News
Financial Hardships Associated With Long COVID Across Income and Education Levels
12/19/2024
Juliet Gallagher
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health Services Research analyzing data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) has revealed a significant association between long COVID and financial hardships.
A study published in Health...
12/19/2024
First Report Managed Care
News
Effectiveness of SARS-CoV-2 Vaccination Among Health Care Workers
12/17/2024
Hannah Musick
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of SARS-CoV-2 vaccination in health care workers shows high levels of protection against infection, symptomatic infection, and hospitalization with evidence of waning immunity over time.
A comprehensive analysis of...
12/17/2024
First Report Managed Care
News
Patients With MS on Ocrelizumab and Rituximab May Have Higher Risk of SARS-CoV-2 Infection Compared to Ofatumumab
05/28/2024
Hannah Musick
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that patients on ocrelizumab and rituximab are at a higher risk of contracting SARS-CoV-2 despite being vaccinated, compared to those on ofatumumab.
Recent research found that...
05/28/2024
First Report Managed Care
News
Risk of Fatal Overdose Decreased With Expanded Access to Telehealth, Medications for OUD During Pandemic
04/03/2023
Hannah Musick
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less likely among Medicare beneficiaries during the COVID-19 pandemic due to increased access to telehealth services and medications for opioid use disorder.
Fatal drug overdoses were less...
04/03/2023
First Report Managed Care
News
SDoH Impact COVID-19 Vaccination Rates Among Patients With Cancer
03/27/2023
Hannah Musick
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and comorbidity status were among several significant factors driving COVID-19 vaccination rates for patients with cancer, new findings show.
Age, cancer type, and...
03/27/2023
First Report Managed Care
News
Woman Develops Retroperitoneal Fibrosis Following COVID-19 mRNA Vaccination
03/23/2023
Jolynn Tumolo
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed...
03/23/2023
First Report Managed Care
News
High-Throughput Assay Tracks Range of SARS-CoV-2 Vaccination Responses
03/22/2023
Jolynn Tumolo
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an immunoassay was efficacious for tracking antibody responses to SARS-CoV-2 vaccination across all ages and infection history.
New research demonstrated an...
03/22/2023
First Report Managed Care
News
Meta-Analysis Supports COVID-19 Vaccines for Adults of All Ages
02/22/2023
Jolynn Tumolo
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that...
02/22/2023
First Report Managed Care
News
Contracting COVID-19 Almost Doubles Long-Term Mortality Rate
02/21/2023
Hannah Musick
Patients who have contracted COVID-19 are at risk for a higher mortality rate than those who have never contracted the disease, findings show.
Patients who have contracted COVID-19 are at risk for a higher mortality rate than those who have never contracted the disease, findings show.
Patients who have contracted...
02/21/2023
First Report Managed Care
News
Illinois FQHCs Deliver More Guideline-Concordant Kidney Disease Testing, Study Finds
02/03/2026
Grace Taylor, MS, MA
Federally qualified health centers (FQHCs) in Illinois outperformed non-FQHC practices in guideline-recommended kidney disease testing, highlighting the strength of the safety-net model in caring for high-risk populations.
Federally qualified health centers (FQHCs) in Illinois outperformed non-FQHC practices in guideline-recommended kidney disease testing, highlighting the strength of the safety-net model in caring for high-risk populations.
Federally qualified health...
02/03/2026
First Report Managed Care
News
Co-occurring ADHD Associated With Poorer Health Outcomes in Adults With Autism on Medicaid
02/02/2026
Grace Taylor, MS, MA
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds...
02/02/2026
First Report Managed Care
News
CMS Finalizes Rule Updating Medicaid Health Care–Related Tax Policies
01/30/2026
Hannah Musick
The Centers for Medicare & Medicaid Services (CMS) finalized a rule updating oversight of Medicaid provider tax arrangements, aiming to reinforce federal–state financing requirements and ensure that Medicaid funds are used for beneficiary...
The Centers for Medicare & Medicaid Services (CMS) finalized a rule updating oversight of Medicaid provider tax arrangements, aiming to reinforce federal–state financing requirements and ensure that Medicaid funds are used for beneficiary...
The Centers for Medicare &...
01/30/2026
First Report Managed Care
News
Optum Rx’s Cost-Based Pharmacy Payments Signal a Major Shift in Drug Reimbursement
01/27/2026
Lisa Kuhns, PhD, MD
Optum Rx’s full transition from community pharmacies to a cost-based reimbursement model marks a significant shift in how prescription drugs are paid for, aiming to stabilize pharmacy finances amid mounting industry pressures.
Optum Rx’s full transition from community pharmacies to a cost-based reimbursement model marks a significant shift in how prescription drugs are paid for, aiming to stabilize pharmacy finances amid mounting industry pressures.
Optum Rx’s full transition from...
01/27/2026
First Report Managed Care
News
Study Projects Billions in Savings From Site-Neutral Payments for Routine Services
01/23/2026
Grace Taylor, MS, MA
A national analysis of 2022 commercial claims data suggests that capping payments for routine services at site-neutral Medicare-based rates could save purchasers and patients $10.8 billion annually with only modest effects on hospital margins.
A national analysis of 2022 commercial claims data suggests that capping payments for routine services at site-neutral Medicare-based rates could save purchasers and patients $10.8 billion annually with only modest effects on hospital margins.
A national analysis of 2022...
01/23/2026
First Report Managed Care
News
Medicare Part D Formularies Remain Broad for IRA-Negotiated Drugs
01/20/2026
Grace Taylor, MS, MA
Despite broad Medicare Part D coverage for Inflation Reduction Act (IRA)-negotiated drugs, data suggest formulary access is narrowing for non-selected therapies—particularly orphan drugs—raising concerns about patient access as price...
Despite broad Medicare Part D coverage for Inflation Reduction Act (IRA)-negotiated drugs, data suggest formulary access is narrowing for non-selected therapies—particularly orphan drugs—raising concerns about patient access as price...
Despite broad Medicare Part D...
01/20/2026
First Report Managed Care
News
US Observational Data Show Variable Real-World Outcomes With JAK Inhibitors in RA
01/19/2026
Juliet Gallagher
Real-world evidence (RWE) is increasingly used to complement randomized controlled trial data in rheumatoid arthritis treatment decision-making. A new study synthesized observational studies evaluating the real-world effectiveness of Janus...
Real-world evidence (RWE) is increasingly used to complement randomized controlled trial data in rheumatoid arthritis treatment decision-making. A new study synthesized observational studies evaluating the real-world effectiveness of Janus...
Real-world evidence (RWE) is...
01/19/2026
First Report Managed Care
News
Miami Drug Wholesaler Enters Federal Opioid Deferred Prosecution Agreement
01/14/2026
Hannah Musick
A Miami pharmaceutical wholesaler admitted to knowingly supplying millions of opioid pills to Houston-area pill mill pharmacies under a federal deferred prosecution agreement, highlighting continued enforcement against opioid diversion across...
A Miami pharmaceutical wholesaler admitted to knowingly supplying millions of opioid pills to Houston-area pill mill pharmacies under a federal deferred prosecution agreement, highlighting continued enforcement against opioid diversion across...
A Miami pharmaceutical...
01/14/2026
First Report Managed Care
News
House Passes Bill to Extend ACA Premium Tax Credits
01/13/2026
Hannah Musick
The US House has advanced a bipartisan-backed bill to extend enhanced Affordable Care Act (ACA) premium tax credits, setting up a high-stakes Senate debate with major implications for insurance affordability and patient access to care.
The US House has advanced a bipartisan-backed bill to extend enhanced Affordable Care Act (ACA) premium tax credits, setting up a high-stakes Senate debate with major implications for insurance affordability and patient access to care.
The US House has advanced a...
01/13/2026
First Report Managed Care
News
Specialist Access Eliminates Racial Gaps in Rheumatoid Arthritis DMARD Use
01/12/2026
Lisa Kuhns, PhD, MD
Racial inequities in access to modern rheumatoid arthritis (RA) therapies persist across the United States, but disappear among patients who reach rheumatology care, according to study results published in The Journal of Rheumatology.
Racial inequities in access to modern rheumatoid arthritis (RA) therapies persist across the United States, but disappear among patients who reach rheumatology care, according to study results published in The Journal of Rheumatology.
Racial inequities in access to...
01/12/2026
First Report Managed Care

Videos

Videos
Factors to Consider When Differentiating Between COVID and Allergy Symptoms
07/21/2020
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how...
07/21/2020
First Report Managed Care
Videos
How I Practice Now: Ensuring Patients Understand the Proper Use of Telehealth
04/02/2020
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist,...
04/02/2020
First Report Managed Care
NSCLC, Oncology Coverage, Oncology Access
Videos
What PALOMA-3 Signals for Coverage, Access, and Care Delivery in NSCLC
02/02/2026
Narjust Florez, MD
In this interview, Narjust Florez, MD, discusses how subcutaneous amivantamab from the PALOMA-3 study may improve patient experience, clinic workflow, and treatment adherence while highlighting ongoing unmet needs and real-world...
In this interview, Narjust Florez, MD, discusses how subcutaneous amivantamab from the PALOMA-3 study may improve patient experience, clinic workflow, and treatment adherence while highlighting ongoing unmet needs and real-world...
In this interview, Narjust...
02/02/2026
First Report Managed Care
Non-Small Cell Lung Cancer
Videos
Optimizing NSCLC Care Through Extended Dosing and Alternative Formulations
01/27/2026
Corrine Stahura, PharmD, BCOP
Corrine Stahura, PharmD, BCOP, discusses how extended dosing intervals and subcutaneous formulations in non–small cell lung cancer are improving patient convenience, reducing infusion center burden, and enhancing operational efficiency while...
Corrine Stahura, PharmD, BCOP, discusses how extended dosing intervals and subcutaneous formulations in non–small cell lung cancer are improving patient convenience, reducing infusion center burden, and enhancing operational efficiency while...
Corrine Stahura, PharmD, BCOP,...
01/27/2026
First Report Managed Care
Non-Small Cell Lung Cancer
Videos
Treatment Paradigms in NSCLC: Chemo-Based vs Non-Chemo Regimens
01/27/2026
Rajat Thawani, MD
Dr Rajat Thawani discusses how biomarker-driven strategies, emerging immunotherapies, and novel delivery approaches are rapidly redefining first-line non-small cell lung cancer (NSCLC) treatment—shifting care beyond traditional chemotherapy...
Dr Rajat Thawani discusses how biomarker-driven strategies, emerging immunotherapies, and novel delivery approaches are rapidly redefining first-line non-small cell lung cancer (NSCLC) treatment—shifting care beyond traditional chemotherapy...
Dr Rajat Thawani discusses how...
01/27/2026
First Report Managed Care
Non-Small Cell Lung Cancer
Videos
Evaluating Total Cost Considerations in Non–Small Cell Lung Cancer Care
01/27/2026
Estelamari Rodriguez, MD, MPH
As new subcutaneous and targeted therapies enter the NSCLC landscape, the true cost of care extends far beyond drug price alone. In this interview, Estelamari Rodriguez, MD, MPH, a thoracic oncologist at Sylvester Comprehensive Cancer Center,...
As new subcutaneous and targeted therapies enter the NSCLC landscape, the true cost of care extends far beyond drug price alone. In this interview, Estelamari Rodriguez, MD, MPH, a thoracic oncologist at Sylvester Comprehensive Cancer Center,...
As new subcutaneous and targeted...
01/27/2026
First Report Managed Care
Saad Ashraf, MD presents Pulmonary Fibrosis webinar
Videos
Redefining Pulmonary Fibrosis Care With Nerandomilast
12/10/2025
Saad Ashraf, MD
In the final chapter of our pulmonary fibrosis webinar series, Dr Saad Ashraf discussed FDA-approved nerandomilast and what its introduction means for clinicians, payers, and patients living with interstitial lung disease.
In the final chapter of our pulmonary fibrosis webinar series, Dr Saad Ashraf discussed FDA-approved nerandomilast and what its introduction means for clinicians, payers, and patients living with interstitial lung disease.
In the final chapter of our...
12/10/2025
First Report Managed Care
Videos
Obesity Drugs for Medicare: What the GLP-1 Pricing Agreement Means for Access
11/20/2025
Adam Colborn, JD
Adam Colborn, JD, associate vice president for congressional affairs at the Academy of Managed Care Pharmacy, discusses how the Trump administration’s “most favored nation” drug-pricing agreements test the limits of executive authority,...
Adam Colborn, JD, associate vice president for congressional affairs at the Academy of Managed Care Pharmacy, discusses how the Trump administration’s “most favored nation” drug-pricing agreements test the limits of executive authority,...
Adam Colborn, JD, associate vice...
11/20/2025
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Videos
From Innovation to Implementation: Rethinking Access in Idiopathic Pulmonary Fibrosis
11/07/2025
Elizabeth Volkmann, MD, MS; Carole Tremonti, RN, MBA
As new therapies for idiopathic pulmonary fibrosis (IPF) emerge, healthcare stakeholders must navigate the balance between innovation and evidence-based coverage decisions. This webinar brings together clinical, regulatory, and payer...
As new therapies for idiopathic pulmonary fibrosis (IPF) emerge, healthcare stakeholders must navigate the balance between innovation and evidence-based coverage decisions. This webinar brings together clinical, regulatory, and payer...
As new therapies for idiopathic...
11/07/2025
First Report Managed Care
Gaballa
Videos
Fixed-Duration Therapy in CLL: Evaluating Long-Term Cost Benefits for Managed Care
10/09/2025
Sameh Gaballa, MD
In this interview, Dr Sameh Gaballa of Moffitt Cancer Center discusses the expanding landscape of chronic lymphocytic leukemia (CLL) therapy, highlighting the role of fixed-duration regimens, real-world implementation challenges, and...
In this interview, Dr Sameh Gaballa of Moffitt Cancer Center discusses the expanding landscape of chronic lymphocytic leukemia (CLL) therapy, highlighting the role of fixed-duration regimens, real-world implementation challenges, and...
In this interview, Dr Sameh...
10/09/2025
First Report Managed Care
Rovin
Videos
Redefining Treatment Goals in IgA Nephropathy: Insights from the KDIGO 2025 Guideline Update
10/03/2025
Brad Rovin, MD
Brad Rovin, MD, chief of nephrology at Ohio State University Wexner Medical Center, discusses how the KDIGO 2025 guidelines mark a major shift in the management of IgA nephropathy, emphasizing earlier diagnosis, lower proteinuria targets, and...
Brad Rovin, MD, chief of nephrology at Ohio State University Wexner Medical Center, discusses how the KDIGO 2025 guidelines mark a major shift in the management of IgA nephropathy, emphasizing earlier diagnosis, lower proteinuria targets, and...
Brad Rovin, MD, chief of...
10/03/2025
First Report Managed Care

Podcasts

Headshot of Norman Smith on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Exploring Commercial Coverage, Reimbursement for COVID-19 Vaccines
05/17/2023
Maria Asimopoulos
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer...
05/17/2023
Integrated Healthcare Executive
Podcasts
Identifying the Benefits of Rapid At-Home Diagnostic Testing and How These Can Communicate With PCPs, Infectious Disease Professionals
10/25/2020
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo...
10/25/2020
First Report Managed Care
Gaballa
Podcasts
Real-World Applications of Fixed-Duration Therapy in CLL: Accessibility, Cost, and Patient Preference
10/09/2025
Sameh Gaballa, MD
In this interview, Dr Sameh Gaballa of Moffitt Cancer Center discusses the expanding landscape of chronic lymphocytic leukemia (CLL) therapy, highlighting the role of fixed-duration regimens, real-world implementation challenges, and...
In this interview, Dr Sameh Gaballa of Moffitt Cancer Center discusses the expanding landscape of chronic lymphocytic leukemia (CLL) therapy, highlighting the role of fixed-duration regimens, real-world implementation challenges, and...
In this interview, Dr Sameh...
10/09/2025
First Report Managed Care
Bhat Headshot
Podcasts
Time-Limited Therapy in CLL: A Value-Based Approach to Modern Oncology
07/08/2025
Seema A. Bhat, MD
Dr Seema Bhat explores how fixed-duration therapies are reshaping chronic lymphocytic leukemia (CLL) treatment, offering real-world insight into clinical decision-making, economic impact, and patient quality of life.
Dr Seema Bhat explores how fixed-duration therapies are reshaping chronic lymphocytic leukemia (CLL) treatment, offering real-world insight into clinical decision-making, economic impact, and patient quality of life.
Dr Seema Bhat explores how...
07/08/2025
First Report Managed Care
Robbins
Podcasts
Improving Access to CGRP Therapies for Effective Migraine Treatment
12/12/2024
Explore the challenges patients face in accessing CGRP therapies for migraines, strategies to streamline treatment effectiveness, and the crucial role of health care providers in navigating access barriers and aligning clinical guidelines...
Explore the challenges patients face in accessing CGRP therapies for migraines, strategies to streamline treatment effectiveness, and the crucial role of health care providers in navigating access barriers and aligning clinical guidelines...
Explore the challenges patients...
12/12/2024
First Report Managed Care
LMW
Podcasts
Understanding Early CGRP Therapy Initiation in Migraine Treatment
11/22/2024
Lucy Myint-Wilks, BMBS, MSc, MRCS
Explore the latest advancements in migraine research, treatment options, cost-effectiveness, and the role of technology in managing migraines in this informative episode.
Explore the latest advancements in migraine research, treatment options, cost-effectiveness, and the role of technology in managing migraines in this informative episode.
Explore the latest advancements...
11/22/2024
First Report Managed Care
Ed
Podcasts
Improving Adherence With Long-Acting Antiretroviral Therapy for HIV
11/15/2024
Edmund J. Pezalla, MD
Join our in-depth discussion about the challenges of HIV treatment, the importance of adherence to antiretroviral therapy, and how long-acting ART can improve treatment outcomes.
Join our in-depth discussion about the challenges of HIV treatment, the importance of adherence to antiretroviral therapy, and how long-acting ART can improve treatment outcomes.
Join our in-depth discussion...
11/15/2024
First Report Managed Care
Sid Devarakonda
Podcasts
Frontline Treatment Landscape Advancements for Non-Small Cell Lung Cancer
08/28/2024
Sid Devarakonda, MD
Tune in as we speak with a guest oncology expert about the progress in treating non-small cell lung cancer, targeted therapies and immunotherapy, and the challenges of early detection and screening options covered by health plans.
Tune in as we speak with a guest oncology expert about the progress in treating non-small cell lung cancer, targeted therapies and immunotherapy, and the challenges of early detection and screening options covered by health plans.
Tune in as we speak with a guest...
08/28/2024
First Report Managed Care
Owens
Podcasts
Understanding the Impact of Formulary Exclusions on Medication Adherence
03/28/2024

Featuring Gary Owens, MD, president of Gary Owens Associates

Featuring Gary Owens, MD, presid...
Join us as guest expert Gary Owens discusses how formulary exclusions can impact patient medication adherence and lead to adverse economic outcomes, making the need for non-medical switching and formulary exception requests an important issue...
Join us as guest expert Gary Owens discusses how formulary exclusions can impact patient medication adherence and lead to adverse economic outcomes, making the need for non-medical switching and formulary exception requests an important issue...
Join us as guest expert Gary...
03/28/2024
First Report Managed Care
Prajapati Podcast
Podcasts
Standardizing the Field of Digital Medicine: Insights from an Industry Expert
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consul...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Shomali Podcast
Podcasts
Expanding Diabetes Care
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, ch...
Discover how digital therapeutics are revolutionizing disease management, patient care, reducing health care costs, and more with Dr Mansur Shomali, CMO at Welldoc.
Discover how digital therapeutics are revolutionizing disease management, patient care, reducing health care costs, and more with Dr Mansur Shomali, CMO at Welldoc.
Discover how digital...
02/27/2024
First Report Managed Care
Larry Hsu Headshot
Podcasts
Expert Insights into Value-Based Care for Polymyalgia Rheumatica
01/11/2024
Larry Hsu, MD
A doctor and expert in value-based care offers insights into treatment costs and treatment regimens for patients with polymyalgia rheumatica.
A doctor and expert in value-based care offers insights into treatment costs and treatment regimens for patients with polymyalgia rheumatica.
A doctor and expert in...
01/11/2024
First Report Managed Care

Insights

Headshots
Commentary
Harnessing Innovation to Improve Maternal Health
04/09/2024

Britteny Matero, partner and senior vice president, Market Access, Innsena, and Jaime Bland, DNP, RN, president and chief executive officer, CyncHealth

Britteny Matero, partner and senior v...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal health crisis, with high maternal mortality rates exacerbated by COVID-19 and racial disparities. Institutional changes are needed to prevent these largely preventable deaths, and two experts highlight...
The US faces a critical maternal...
04/09/2024
First Report Managed Care
Headshot of Norman Smith on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Exploring Commercial Coverage, Reimbursement for COVID-19 Vaccines
05/17/2023
Maria Asimopoulos
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer...
05/17/2023
Integrated Healthcare Executive
Headshot of Dr Michael Stearns, Wolters Kluwer, Health Language
Interview
2022 Risk Adjustment Factor Scores: Changing Tech, Data Strategies Postpandemic
03/10/2022
Maria Asimopoulos
Michael Stearns, MD, CPC, CRC, CFPC, specialized consulting director of medical informatics, Wolters Kluwer, Health Language, breaks down how payers must approach risk adjustment factor scores differently after the pandemic disrupted regular...
Michael Stearns, MD, CPC, CRC, CFPC, specialized consulting director of medical informatics, Wolters Kluwer, Health Language, breaks down how payers must approach risk adjustment factor scores differently after the pandemic disrupted regular...
Michael Stearns, MD, CPC, CRC,...
03/10/2022
First Report Managed Care
Archelle Georgiou, MD CaringBridge
Commentary
How Connection and Social Support Help Those Suffering From Long COVID
08/05/2021
Archelle Georgiou, MD
Archelle Georgiou, MD, discusses long COVID—which impacts those experiencing symptoms for weeks or months after recovering from the disease—and explains what those in the health care industry should know and why love and support can help...
Archelle Georgiou, MD, discusses long COVID—which impacts those experiencing symptoms for weeks or months after recovering from the disease—and explains what those in the health care industry should know and why love and support can help...
Archelle Georgiou, MD, discusses...
08/05/2021
First Report Managed Care
Population Points
A COVID-19 Hangover
06/18/2021
Mitch Kaminski, MD, MBA
Mitch Kaminski, MD, MBA, editor-in-chief, Population Health Learning Network, discusses the after-effects of the pandemic as cases have begun to drop, highlights how “a new normal” may challenge our fee-for-service based health care system,...
Mitch Kaminski, MD, MBA, editor-in-chief, Population Health Learning Network, discusses the after-effects of the pandemic as cases have begun to drop, highlights how “a new normal” may challenge our fee-for-service based health care system,...
Mitch Kaminski, MD, MBA,...
06/18/2021
First Report Managed Care
Commentary
Looking Ahead: Three Imperatives for Recovering Health Systems
02/25/2021
"While hospitals dealt with the sudden patient influx caused by COVID-19, distributors confronted the challenge of maintaining a steady supply of essential products and medications to treat a disease that seemed almost invincible," said...
"While hospitals dealt with the sudden patient influx caused by COVID-19, distributors confronted the challenge of maintaining a steady supply of essential products and medications to treat a disease that seemed almost invincible," said...
"While hospitals dealt with the...
02/25/2021
First Report Managed Care
Population Points
Confronting Vaccine Hesitancy
02/12/2021
Mitch Kaminski, MD, MBA
Mitch Kaminski, MD, MBA, editor-in-chief, discusses his recent experience with a patient regarding vaccine hesitancy, breaks down the history of anti-vaccine sentiment, and explains why vaccine hesitancy is about much more than just the...
Mitch Kaminski, MD, MBA, editor-in-chief, discusses his recent experience with a patient regarding vaccine hesitancy, breaks down the history of anti-vaccine sentiment, and explains why vaccine hesitancy is about much more than just the...
Mitch Kaminski, MD, MBA,...
02/12/2021
First Report Managed Care
Podcasts
Identifying the Benefits of Rapid At-Home Diagnostic Testing and How These Can Communicate With PCPs, Infectious Disease Professionals
10/25/2020
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why...
Ron Chiarello, PhD, CEO, Alveo...
10/25/2020
First Report Managed Care
Videos
Factors to Consider When Differentiating Between COVID and Allergy Symptoms
07/21/2020
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how health care professionals can identify allergic asthma triggers in the age of social distancing and highlights factors that should be considered when differentiating between COVID-19 and general allergy...
Lakiea Wright, MD, explains how...
07/21/2020
First Report Managed Care
Videos
How I Practice Now: Ensuring Patients Understand the Proper Use of Telehealth
04/02/2020
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Nana Duffy, MD, dermatologist,...
04/02/2020
First Report Managed Care

Interactive Features

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

News
Task Force Publishes Target-To-Treat Guidance for GCA and PMR
03/12/2024
Jolynn Tumolo
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force...
03/12/2024
First Report Managed Care
Asembia: More Than an Annual Conference
04/15/2024

Emry Lloyd

Emry Lloyd
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005,...
04/15/2024
First Report Managed Care
Conference Coverage
Addressing Suicidal Ideation in Persons With Multiple Sclerosis: Developing a Predictive Nomogram
05/22/2024
Hannah Musick
New research explored the development of a predictive nomogram to identify persons with multiple sclerosis at higher risk of suicidal ideation, emphasizing the importance of behavioral risk factors in this vulnerable population.
New research explored the development of a predictive nomogram to identify persons with multiple sclerosis at higher risk of suicidal ideation, emphasizing the importance of behavioral risk factors in this vulnerable population.
New research explored the...
05/22/2024
First Report Managed Care
News
Johnson & Johnson Expands Use of Prezcobix for Pediatric Patients in the US
06/21/2024
Hannah Musick
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand...
06/21/2024
First Report Managed Care
Brian Esterly Headshot
Interview
Insights on the 2024 Medicare Physician Fee Schedule: Implications and Opportunities for Virtual Care Management Services
07/26/2024
The current Medicare Physician Fee Schedule brought many significant changes to increase access to much needed virtual care management (VCM) services to underserved populations. Learn more about the potential implications of these fee...
The current Medicare Physician Fee Schedule brought many significant changes to increase access to much needed virtual care management (VCM) services to underserved populations. Learn more about the potential implications of these fee...
The current Medicare Physician...
07/26/2024
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use